Partners

Clinical and Scientific Consortium, Distinguished Members

W. Randolph Chitwood, Jr. M.D.
Emeritus Professor and Chairman, Department of Surgery; Emeritus Professor, Department of Cardiovascular Studies;
Brody School of Medicine, East Carolina University
Greenville, NC

Joseph DeSimone, PhD
Chancellor’s Eminent Professor of Chemistry, University of North Carolina at Chapel Hill;
William R. Kenan, Jr. Distinguished Professor of Chemical Engineering, North Carolina State University
Chapel Hill, NC

Pascal J. Goldschmidt, M.D.
Senior Vice President for Medical Affairs, Dean, University of Miami Leonard M. Miller School of Medicine;  Chief Executive Officer of the University of Miami Health System
Miami, Fl

Joseph C Greenfield, Jr., M.D.
James B. Duke Professor of Medicine, Division of Cardiology, Duke University Medical Center
Durham, NC

James B Hermiller, Jr., M.D., FACC, FSCAI
Director of Interventional Cardiology and Interventional Cardiology Fellowship Director, St.Vincent Heart Center of Indiana
Indianapolis, IN

Andy C. Kiser, M.D., FACS, FACC, FCCP
Professor of Surgery, UNC School of Medicine
Chief, Division of Cardiothoracic Surgery
Associate Director for Academic Operations, UNC Center for Heart and Vascular Care
Chapel Hill, NC

William Knopf, M.D.
Vice-President, US Customer Engagement at The Medicines Company
Atlanta, GA

William O’Neill, M.D., F.A.C.C., F.S.C.A.I.
Medical Director, Center for Structural Heart Disease, Henry Ford Hospital,
Detroit, MI

Harry R Phillips, M.D.
Professor of Medicine, Associate Director, Duke Heart Center; Chief Medical Officer, Duke Heart Network, Duke University Medical Center,
Durham ,NC

Gary S Roubin, M.D., PhD
New York, NY

Barry D Rutherford, M.D., FACC
Director of Interventional Cardiology Program Mid-America Heart Institute, St Luke’s Hospital
Critical Professor of Medicine, University of Missouri,
Kansas City, MO

Thomas J Ryan, M.D.
Director, Ohio State University Heart and Vascular Center
Professor of Cardiovascular Medicine, Ohio State Medical Center,
Columbus, OH

Judith Swain, M.D.
Executive Director, Singapore Institute for Clinical Sciences within A*STAR
Lien Chow Professor of Medicine, National University of Singapore
Singapore

H. Lee Sweeney, PhD.
William Maul Measey Professor
Director, Center for Orphan Disease Research and Therapy
Perelman School of Medicine, University of Pennsylvania,
Philadelphia, PA

Renu Virmani, M.D., FACC
President, Medical Director, CVPath Institute,
Gaithersburg, MD

Paul Yock, M.D.
Martha Meier Weiland Professor of Medicine
Director, Biodesign; Founding Co-Chair , Department of Bioengineering
Stanford University,
Stanford, CA

synergy

About Synergy Life Science Partners: Synergy Life Science Partners is a venture capital firm that focuses on investing in private, early stage medical device companies or emerging companies who are combining a medical device with a therapeutic payload (drugs, biologics, etc.) — the “combination product” opportunities. synergylsp.com

abv

About Ascent Biomedical Ventures: Ascent Biomedical Ventures (ABV) is a venture capital firm investing in seed and early-stage biomedical technology companies developing medical devices, biopharmaceuticals, healthcare services, and information technology. ABV’s principals and advisors work closely with entrepreneurs to manage the risks associated with deploying capital in startup companies. abvlp.com

abbott

About Abbott Vascular: Abbott Vascular, a division of Abbott, is one of the world’s leading vascular care businesses. Abbott Vascular is uniquely focused on transforming the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development and advancing medicine through training and education. abbottvascular.com

jnj

About Johnson & Johnson Development Corporation: Organized in 1973, Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. JJDC also leads and manages internal investments in selected promising technologies. jjdevcorp.com

Medtronic

About Medtronic Inc: Medtronic is the world’s largest medical technology company, offering an unprecedented breadth and depth of innovative therapies to fulfill our Mission of alleviating pain, restoring health, and extending life. Last year, more than 9 million people benefited from our medical therapies, which treat cardiac and vascular diseases, diabetes, and neurological and musculoskeletal conditions. With a global reach that extends to more than 140 countries, we have a deep understanding of many universal healthcare challenges. We’re using our experience, extensive partnerships, and the passion of 46,000+ employees to help transform healthcare worldwide by improving outcomes, expanding access, and enhancing value.

Piedmont2

 

 

About Piedmont Capital Partners, LLC: Piedmont Capital Partners is a boutique investment firm with offices in Greensboro, North Carolina. We focus on early stage North Carolina companies and entrepreneurs.

abbott

About Abbott Vascular: Abbott Vascular, a division of Abbott, is one of the world’s leading vascular care businesses. Abbott Vascular is uniquely focused on transforming the treatment of vascular disease and improving patient care by combining the latest medical device innovations with world-class pharmaceuticals, investing in research and development and advancing medicine through training and education.

abbottvascular.com

ge

About GE Medical Systems: GE Medical Systems is a $7 billion global leader in medical systems, information and technology. Its offerings include networking and productivity tools, healthcare information systems, patient-monitoring systems, conventional and digital X-ray, computed tomography (CT), magnetic resonance (MR), ultrasound, positron emission tomography (PET), and nuclear medicine systems. With global headquarters in Waukesha, Wisconsin, healthcare providers worldwide rely on GE Medical Systems for high quality medical technology, services and productivity solutions.

gemedicalsystems.com

jnj

About Johnson & Johnson Development Corporation: Organized in 1973, Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. JJDC also leads and manages internal investments in selected promising technologies. jjdevcorp.com

Medtronic

 

About Medtronic Inc: Medtronic is the world’s largest medical technology company, offering an unprecedented breadth and depth of innovative therapies to fulfill our Mission of alleviating pain, restoring health, and extending life. Last year, more than 9 million people benefited from our medical therapies, which treat cardiac and vascular diseases, diabetes, and neurological and musculoskeletal conditions. With a global reach that extends to more than 140 countries, we have a deep understanding of many universal healthcare challenges. We’re using our experience, extensive partnerships, and the passion of 46,000+ employees to help transform healthcare worldwide by improving outcomes, expanding access, and enhancing value.

Boston Scientific

 

 

About Boston Scientific: Our products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women’s health, and chronic pain conditions. We continue to innovate in these areas and are extending our innovations into new geographies and high-growth adjacency markets.

Synecor: a Thomas Edisonian creation of forefront ideas in medical devices!Louis Lange, Ph.D., M.D., CEO, CV Therapeutics, Inc.

Board of Directors

Richard S. Stack, M.D., F.A.C.C., Synecor

William N. Starling, Synecor

H. Michael Cohen, Deutsche Bank

Steve Hochberg, Deerfield Management

William Knopf, M.D., St. Vincent Healthcare

R. Frederick McCoy, Jr., NeuroTronik, Inc.

Mudit Jain, Synergy Life Science Partners, LP

Robert Taber, Ph.D.

Daniel Sheehan, Medtronic, Inc.

Kadir Kadhiresan, Johnson & Johnson Development Corp.

Executive Committee

Richard S. Stack, M.D., F.A.C.C., Synecor

William N. Starling, Synecor

Steve Hochberg, Deerfield Management

Daniel Sheehan, Medtronic, Inc.

Ray Larkin, former CEO of Nellcor Inc.

Mudit Jain, Synergy Life Science Partners, LP

Kadir Kadhiresan, Johnson & Johnson Development Corp.

Richard S. Stack, M.D., F.A.C.C. President, Synecor, LLC
William N. Starling Chief Executive Officer, Synecor, LLC
R. Frederick McCoy, Jr.Vice Chairman, Synecor, LLC